Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

NCT02315066 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
174
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer